Does Antidepressant Use Blunt Adaptations to Exercise?

California State University, San Marcos

Status: Unknown

Conditions: Depression; Metabolic Syndrome; Depressive Disorder

Treatments: Behavioral: Exercise

Study type: Interventional

Funder types: Other

Identifiers

NCT03934723

1423972-1

Details and patient eligibility

About

Nearly one out of ten US adults over the age of 18 currently takes antidepressant medication, which can also treat other conditions such as anxiety. Combining pharmaceutical treatment with exercise may yield even greater benefits than using drugs alone, and this is commonly prescribed for depression. However, little is known about the drug-exercise interactions and their influence on metabolic health. A common side effect of antidepressant use is weight gain, particularly abdominal (visceral) fat, which is highly detrimental to overall health. Exercise is a well-known counter to abdominal fat accumulation. The aim of the proposed study is to compare the efficacy of 6 weeks of exercise training to reduce abdominal fat in healthy overweight/obese adults either taking or not taking antidepressant medication. Twenty-four inactive overweight/obese, but otherwise healthy, adults will complete 6 weeks of an exercise training intervention consisting of three days of aerobic exercise training per week. Participants will either not be taking antidepressant medication or will have been on their medication for at least 1 year. The primary outcome will be abdominal fat determined by waist circumference and dual x-ray absorptiometry, which is considered one of the optimal methods for assessment of abdominal fat.

Enrollment: 24 estimated patients

Sex: All

Ages: 18 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Participants will be English language speakers
• Male or females between the ages of 18-40.
• All genders and ethnicities.
• Healthy as assessed by a health history questionnaire (no diagnosed physical diseases or conditions preventing participation in exercise).
• Individuals on antidepressants will be recruited if they are consuming selective serotonin reuptake inhibitors (SSRIs) and selective serotonin and norepinephrine reuptake inhibitors (SNRIs) only. Participants will send prescription information after consent has been provided as part of the screening process, including the dose and frequency of medication.
• A body mass index (BMI) of 25 or greater is required for inclusion.

Exclusion criteria

• Inability to complete moderate-vigorous exercise.
• Taking first generation antidepressant medications or other medications such as monoamine oxidase inhibitors (MAOI).
• Other medications, such as medications for attention-deficit hyper-activity disorder or metabolism
• Undiagnosed depression that may be unveiled during the screening process.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

24 participants in 2 patient groups

Control

Active Comparator group

Description:

This arm will consist of healthy overweight and obese individuals who are physically inactive and do not have clinically diagnosed depression or depression symptoms.

Treatment:

Behavioral: Exercise

Antidpressants

Experimental group

Description:

This arm will consist of healthy overweight and obese adults who are physically inactive and who are diagnosed with clinical depression and have been taking antidepressant medications for at least 1 year.

Treatment:

Behavioral: Exercise